Medical Transcription Terms

Rheumatology

Common Abbreviations:  
Common Terms:
Medications: Bextra
Procedures/Reports:
Links:  Labs, Painful Shoulder
ANA:  Staining Pattern
Anti-Scl-70 antibody test (Antiscleroderma – 70 Antibodies):  Differential diagnosis of scleroderma (progressive systemic sclerosis); Scl-70 antibody is seen in 20% of patients with scleroderma, and in some patients with CREST syndrome (calcinosis, Raynaud, esophageal dysfunction, sclerodactyly, telangiectasia). These syndromes are also associated with a high frequency of speckled pattern immunofluorescent antinuclear antibody tests. Scl-70 may identify a subset of scleroderma patients with severe skin, joint, and lung disease. In addition, the presence of Scl-70 in Raynaud phenomenon may indicate a poor prognosis.
Anti-SSA, SSA, Sjögren's Antibodies (Anti-SS-A, Anti-SS-B):  Synonyms (Anti-Ro, Anti-La); Aids in the diagnosis of Sjögren's syndrome (especially with vasculitis) and lupus patients with Sjögren's overlap syndrome.   SS-A(Ro) is found in 60% to 70% of patients with Sjögren's syndrome and 30% to 40% of patients with SLE. SS-B(La) is found in 50% to 60% of Sjögren's syndrome and 10% to 15% of SLE. SS-A cannot be demonstrated by immunofluorescence (it is soluble in the buffers used) but SS-B may be seen as a speckled antinuclear pattern. SS-A and SS-B are particularly useful in "ANA negative" cases of SLE, being present in a majority of such cases. Patients who are ANA positive and who have SS-A but not SS-B are very likely to have nephritis. Antibodies to SS-A are also associated with HLA loci DR3 and DR2 and with hereditary deficiency of C2. Anti-SS-A and anti-SS-B are found in virtually all children with neonatal lupus. Patients with SS-A may also have antibodies to cardiolipin, lupus anticoagulant, and clinical thromboses. This has been termed antiphospholipid antibody syndrome.
Bextra:  Once-daily prescription Bextra provides the kind of 24-hour relief many arthritis sufferers are looking for. It’s tough on pain and inflammation.
calcium pyrophosphate deposition disease (CPDD) is a variety of arthritis caused by the deposition of calcium pyrophosphate crystals. CPDD is divided into several varieties, primarily pseudogout and chondrocalcinosis
dermatomyositis

Medical Transcription Terms Home Page